MSR1 and metabolic dysfunction-associated steatotic liver disease: MSR1 transcript levels are significantly associated with the incidence of hepatic steatosis, cirrhosis, and hepatocellular carcinoma in patients with NAFLD; and MSR1 protein expression also increases with disease progression (8).